1/74
Looks like no tags are added yet.
immunocompromised
having a weakness or defect in the innate or adaptive defenses
physical barriers against invading microorganisms
skin and mucous membranes
symbiosis
living together of two dissimilar organisms or symbionts
microbiome
the community of microorganisms, as well as their geetic information, in a given environment
primary pathogen
amicrobe able to cause in an otherwise healthy individual
oppotunistic pathogen
a microbe that causes disease only when introducedinto an unusual location or into an immunocompromised host
virulence
the degree of pathogenicity
colonization
establishmentand growth of a microorganissm on a surface
infection
colonization by a pathogen on or within the body, used if there is a parasitic relationship betwen the microbe and the ost
disease
a condition that prevent the body from functioning normally
symptoms
subjetive efects of disease experienced by the patient like paina and nausea
signs
objective evidence of disease such as rash, pus formation, and sweling (things you can see)
primary pathogen
can cause disease even in an healthy individual
opportunistic pathogen
causes disease only when the body'ds defenses are weakened
virulence factors
traits of a microoranism that specifically allow it to cause disease (the genes for these traits can sometimes be transferred horizontally)
infectious dose
number of microbes necessary to establish an infection
bacteremia
presence of bacterial cells circulating in the blood
toxemia
indicated that toxins are ciculating in the bloodstream
viremia
indicates that viral particles are circulating in the bloodstream
adhesin molecules
a component of microorganisms that bacteria use to atach to host cells that are located most commonly on the tips of pili, the fimbriae, and other surface structures
receptor
where the adhesin attaches and each has distinct roles for the host (typically are glycoproteins, glycolipids)
factors causing individuals to be immunocompromised
genetic defects, malnutrition, infancy, elderly, stress, immunosuppressive drugs, and someinfections
primary pathogen
causes disease in a healthy host with intact immune defenses
how do pathogens overcome barriers to colonization
motility through the fflagella is used to penetrate mucus layers, produce enymes (mucinase or IgA protease) to break down mucus and secretory antibodies, competing with normal microbiota for nutrients and binding sites
What happens when effetor proteins are injected into human cells through a Type III secretion system?
They are like a syringe and reprgram the host cell to be able to do phagocytosis by rearranging their cytoskeleton and engulf the bacteria, this dirupts cell signaling trigeringcell apoptosis
pathogenic mechanisms to penetrate the skin
entry through wounds, burns, insect/animal bites, medical devicesor any other opening
pathogenic mechanisms to penetrate mucus membranes
passing pathogens through the M cells in mucosal tissue as they are specialized sampling cells, inducing endocytoss through epithelial cells, or moving between cells by breaking down tight junctions
How do bacteria avoid innate host and adaptive defenses
hiding within host cells
avoiding complement/phhagocytosis
surviving inside phagocytes
avoiding antibodies
why is damaging host cells good for bacteria?
releases nutrients from dead cells, allows deeper spread into tissues, eliminates competing host immune cells, and triggers symptoms that facilitate transmission to new hosts
exotoxins
proteins secreted by gram + and - bacteria, that are heat lalibble, have a very high potency,causes specific damage, and can form toxoids
endotoxins
lipid portion of LPS in the outer membrane of gram - bacteria only that are released from apoptosis, is heat stable with lower potency, triggers general systeic inflammation
strategies viruses use to outsmart innate and adaptive defenses
antigenic variation
blocking MHC 1 presentations
inhibiting interferon/apoptosis
antigenic variation
mutating surface spikes rabpily so existing antibodies no longer recognize them
blocking MHC 1 presentation
preventing infected cells from displaying ciral antigens to Tc cells
inhibiting interferon/apoptosis
prducing proteins that block host interferon signaling or prevent the infected cells from self-destructing before viral replication finishes
naturally acquired active immunity
exposure to a live pathogen through natural infection, host makes own antibodies and memory cells
artifically active immunity
vaccination with weakend/dead pathogen or anitgen, hos tmakesown antibodies and memory cells (long lasting)
naturally acquired passive immunity
antibodies passed from mother to baby via placenta (IgG) or breast milk, IgA, immediate protection, no memory (temporary)
artifically acquired passive immunity
injection of pre-formed anitbodies/antiserum, immediate protection, no memory (temporary)
attenuated vaccines
live-weakened, replicates in host,strong long lasting cell-mediated and humoral immunity, usually 1 dose
rise of reverion to virulence, unsafe for immunocompromised/pregnant individuals, requires strict refrigeration
inactivated vaccines
killed/subunit, cannot replicate or cause disease, very safe and stable
weaker immune eresponse since mostly humoral, requires boosters and adjuvants
nucleic acid vaccines
fast to manufacture and design, triggers strong humoral and Tc cell responses without a live pathogen
requires ultra cold storage (especially with mRNA), causes temporary inflammatory side eeffects
Whole-agent inactivted
entire microbe killed via heat or chemicals
subunit inactivated vaccines
only purified antigenic pieces of the microbe
toxoid inactivated
inactivated bacterial toxins that still stimulate antitoxin antibodies
conjugate inactivated vaccines
bacterial polysaccharides linked to a carrier protein to help infants mount a T-dependent response
how does an mRNA vaccine create artificial immunity
lipid nanoparticles deliver spike mRNA into human muscle/dendritic cells
host ribosomes translate the mRNA directly in the cytoplasm into viral spike proteins without transcription
innate receptors sense the mRNA/lipids and triggers local inflammaitons
host cells display spike fragment on MHC 1 and MHC 11 molecules
helper T cells activate B cells, producing neutralizing anti-spike antibodies, and Tc cells, leaving behind long-lived memory B and T cells
how are known antibodies used to find unknown antigens
directly detects itself, or its proteins, in a patient sample
how are known antigens used to detect unknown antibody?
detects whether the patient's immune sytem has produced antibodies against a specific pathogen
direct immunoasay test
using a single enzyme-labeled primary antibody that binds dirretly to the target antigen
indirect immunoassy test
detects patient antibodies using a known antigen immobilized on a plate, followed by an unlabeled patient anitbody,and finally a labeled anti-human secondary antibody
COVID-19 PCR test
targets viral RNA from a nasal/saliva swab, that is slow in speed, it has the highest sensitivity or specificity, and diagnoses an active infection
COVID-19 antigen test
targets viral surface proteins through a nasal swab, it is fast, has moderate sensitivity, and diagnoses active infection
COVID-19 antibody test
targets the patients IgM/IgG antibodies in the blood serum, is fast to moderate in speed, is very reliable for ast exposure but not for early infection, is used to determine prior infection or vaccination
Aggulation tests
immunoassays where multivalent antibodies cross link particulate antigens into visible clumps. used for blood typing and rapid pathogen identification
Influenza symptems and pathogenesis
causitive agent: influennzavirus
sudden high fever, chills, severe myalgia, headahe, fatigue, dry cough, and sore throat
HA binds respiratory epithelial cells, viral replication kills ciliated epithelial cells, stripping the mucociliary escalator and prediposing the host to secondary bacterial pneumonia
influenza epide., treatment, and prevention
spreads through respiratory droplets and aerosols, peaks seasonally in winter, birds and pigs serves as major reservoirs
neuraminidase inhibitors or cap-dependent endonuclease inhibitos taken within 48 hours of symptom onset
annual quadrivalent/trivalent flu vaccines and respiratory hygiene
antigenic drift
minor, gradual point mutation in HA and NA genes, causes seasonal epidemics because existing antibodies only partially recognize the altered spikes
antigenic shift
major, abrupt reassortment of segmented RNA genomes when two different flu strains infect the same host cell. creates a novel virus subtype causing global pandemics
how do vaccines provide herd immunity
when a high percenage of a pop. is imunizzed, transmission chains are broken because the pathogen runs out of susceptible hosts, indirectly protecting vulnerable individuals who cannot be vaccinated
why are rates recorded rather than raw number of infected individuals
rates account for total pop. size and a specific time frame, which allows for fair comparison between cities or countries of vastly different sizes
incidence
number of new cases during a specific time period
prevalance
total number of existing cases at a given time
morbidity
rate of illness/disease in a population
mortality
rate of death cause by a disease in a population
case fatality-rate
the percentage of individuals diagnossed with a speciic disease who die from that disease within a givven time frame
(deaths confirmed/confirmed cases)*100
spradic
occurs occasionally and irreegularly in isolated cases
endemic
constantly present at a predictable, baseline level in a specific geographic area
outbreak
a sudden, localized spike in casees above the expected baseline
epidemic
a widespread, rapid increase in cases above normal expectation across a larger region or country
pandemic
an epidemic that spreads across multiple continents or worldwide
chain of infection
infectious agent —> reservoir -→ portal of exi —> mode of transmission —> portal of entry -→ susceptible host
infectious dose nfluence disease epi
low —- allows rapid person to person spread from tiny exposures
incubation period influence disease epi
long ---- allow infected people to unknowigly transmit the pathogen for nomonths/years before symptoms appear
host pop. influence disease epi
high pop- density, low vaccination rates, malnutirtion, or large elderly/immunocompromised groups accelerate outbreaks